ÂÜÀòÂÒÂ×

The Pharmaceutical Research and Development team at Mablink Bioscience focuses on advancing innovative Antibody Drug Conjugates (ADCs) for cancer treatment. This interdisciplinary team conducts cutting-edge research in medicinal chemistry, preclinical testing, and translational studies to optimize drug efficacy and safety, ultimately paving the way for new therapeutic options in oncology. Their collaborative efforts aim to bridge laboratory discoveries with clinical applications, ensuring that promising treatments reach patients effectively.